Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunotherapy With MK-3475 in Locoregionally Advanced, Surgically Resectable Head and Neck Squamous Cell Carcinoma

NCT02296684 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02296684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02296684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunotherapy With MK-3475 in Locoregionally Advanced, Surgically Resectable Head and Neck Squamous Cell Carcinoma
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Completed
Start date
March 25, 2015
Completion date
July 21, 2025
Enrollment
67 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of head and neck, carcinoma, squamous cell of head and neck, head and neck cancer, neoplasms, head and neck, squamous cell carcinoma of the head and neck, squamous cell carcinoma, head and neck